InvestorsHub Logo
Followers 64
Posts 5557
Boards Moderated 0
Alias Born 01/17/2005

Re: masterlongevity post# 757

Thursday, 03/11/2010 7:15:52 PM

Thursday, March 11, 2010 7:15:52 PM

Post# of 890
<" After reading the transcript, it is clear that kelyl martin doesn't know anything about science or drug devlopment and shouldnt be talking publicly about the pipeline. ">

Well I would be worried if they made him CMO. I neither like or dislike him, but I recall Adam F's hatchet job on him was devoid of a single quotation - because as far as I could tell, he said nothing wrong. He was NOT the first to say "absolutely spectacular" - that was the Wyeth guys - and that was in the context of moving Bapi to p3 on the basis of the p2 first look - which was not only an "IF", it actually did NOT happen upon that look. But it lived on in message boards, and I guess Adam F reads such boards.

Anyway, this MDVN failure throws open the Alz race, or perhaps closes it as a one-horse race. I am back into Elan, intending to own it without ever having to look at the imploded mood of the IV board. I suppose "never" is impossible, but its a no-brainer, they simply have too many shots on goal, or rather, canons on goal.

Plus it has 50% the valuation of VRTX, and similar to OSIP. Really the Alz program comes for free. In fact I think even the ACOR royalties come for free !